Skip to main content
Filing year 2023

Dana-Farber Cancer Institute Inc

Boston, Massachusetts·EIN 04-2263040·NTEE H300 · Medical Research·3
Total revenue
$3.5B
Total assets
$5.3B
Total expenses
$0
Reported officers
89

Executive compensation, broken down

Form 990 · Schedule J · 19 reported individuals · Filing year 2023

Base salaryBonusOther compensationBenefits
Base salaryBonusOther compensationBenefitsExecutive compensation
Trustee, President & CEO
board member
$2.5M
Former Key Employee
highest compensated employee
$1.3M
CFO & Assistant Treasurer
$1.1M
Chief Medical Officer
key employee
$1M
SVP & Chief Philanthropy Officer
senior vice president
$1M
Chair Executive Committee for Clinical Programs
board chair
$908k
Chair of Pediatric Oncology
board chair
$901k
Milford MED Dir-hematology/oncology
highest compensated employee
$891k
Sr. Advisor to President & CEO
$823k
Chief Clinical Research Officer
key employee
$810k
Asst Secretary & General Counsel
secretary (operational)
$775k
SVP Chief Administrative Officer
senior vice president
$739k
Chief Scientific Officer
key employee
$719k
Sr. Advisor to President & CEO
$605k
VP of Facilities Management & Real Estate
vice president
$479k
Counsel
former officer/director/trustee
$456k
Sr. VP of Pharmacy & CPO
vice president
$446k
Chair of Medical Oncology
board chair
$224k

Plus 70 unpaid individuals.

Browse compensation in Medical Research

Up 5%
from 2022

From $2.3M in 2022 to $2.5M in 2023.

$2.3M
2022
$2.5M
2023
Highest reported compensation in each year. Volunteer board members and partial-year payouts are filtered out.

Among peers

Revenue and top compensation, plotted against similar organizations. This organization is highlighted in cyan.

Free, forever
Build lists. Save your benchmarks.
A free Lucido account lets you build lists of nonprofits and save your search filters. No credit card.
Create free account
Already a member? Sign in
Build a benchmark

Compare any role, sector, or revenue band

Build your own benchmark from millions of reported positions.